ASAN three-lens brief
Evidence-based stock research on ASAN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +3.76% yesterday. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Moved +3.76% yesterday.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $10.04 — 17% above current (13 analysts).
- Debt-to-equity of 248% — balance-sheet-heavy.
- 10-Q filing filed 2026-09-03.
ASAN closed at $8.56 (+3.76%) as of 2026-09-11. Market cap: $1.96B. Price is above the 50-day MA and below the 200-day MA. Positives: moved +3.76% yesterday.; analyst mean target $10.04 — 17% above current (13 analysts).. Concerns: currently unprofitable on a trailing basis — no P/E multiple available.; debt-to-equity of 248% — balance-sheet-heavy.. Last quarter: Revenue $216.43M, net income -$39.19M, free cash flow $197.05M.
Why three lenses on ASAN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ASANacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ASAN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ASAN brief"></iframe>